Anika Therapeutics (ANIK) Short Interest Ratio & Short Volume $24.64 +0.22 (+0.90%) (As of 09/13/2024 06:55 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Anika Therapeutics Short Interest DataAnika Therapeutics (ANIK) has a short interest of 676,700 shares, representing 4.74% of the float (the number of shares available for trading by the public). This marks a 0.21% increase in short interest from the previous month. The short interest ratio (days to cover) is 14.5, indicating that it would take 14.5 days of the average trading volume of 63,061 shares to cover all short positions.Current Short Interest676,700 sharesPrevious Short Interest675,300 sharesChange Vs. Previous Month+0.21%Dollar Volume Sold Short$17.39 millionShort Interest Ratio14.5 Days to CoverLast Record DateAugust 31, 2024Outstanding Shares14,587,000 sharesFloat Size14,290,000 sharesShort Percent of Float4.74%Today's Trading Volume36,600 sharesAverage Trading Volume63,061 sharesToday's Volume Vs. Average58% Short Selling Anika Therapeutics? Sign up to receive the latest short interest report for Anika Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartANIK Short Interest Over TimeANIK Days to Cover Over TimeANIK Percentage of Float Shorted Over Time Ad Monetary GoldBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. Anika Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/31/2024676,700 shares $17.39 million +0.2%4.7%14.5 $25.70 8/15/2024675,300 shares $17.25 million +0.9%4.7%13.8 $25.54 7/31/2024669,200 shares $18.24 million -6.0%4.7%12.9 $27.25 7/15/2024712,200 shares $19.62 million -2.9%5.0%13.4 $27.55 6/30/2024733,200 shares $18.57 million 0.0%N/A13.7 $25.33 6/15/2024733,400 shares $19.27 million -1.5%N/A12.9 $26.28 Get the Latest News and Ratings for ANIK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anika Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/31/2024744,500 shares $19.10 million -5.6%N/A11.1 $25.65 5/15/2024788,500 shares $20.56 million -2.4%N/A10.2 $26.08 4/30/2024808,100 shares $20.92 million -0.4%5.6%10.1 $25.89 4/15/2024811,100 shares $20.53 million +5.3%5.7%9.9 $25.31 3/31/2024770,400 shares $19.57 million +0.6%5.4%9 $25.40 3/15/2024766,100 shares $19.49 million +32.4%5.4%9.1 $25.44 2/29/2024578,500 shares $14.05 million +1.1%4.1%7.5 $24.28 2/15/2024572,300 shares $14.07 million +8.4%4.0%6.9 $24.59 1/31/2024527,800 shares $12.41 million +1.2%3.7%6.5 $23.52 1/15/2024521,700 shares $11.68 million -3.2%3.7%6 $22.38 12/31/2023538,900 shares $12.21 million +6.9%3.8%5.7 $22.66 12/15/2023504,200 shares $11.25 million -3.6%3.5%4.9 $22.32 11/30/2023523,000 shares $11.46 million +6.9%3.7%2.9 $21.91 11/15/2023489,100 shares $10.02 million -7.5%3.4%2.4 $20.49 10/31/2023528,900 shares $10.31 million +13.0%3.7%2.5 $19.50 10/15/2023468,200 shares $8.75 million +7.2%3.3%2.2 $18.68 9/30/2023436,700 shares $8.14 million -55.0%3.4%2.2 $18.63 9/15/2023971,300 shares $16.97 million +21.5%6.8%4.8 $17.47 8/31/2023799,200 shares $14.27 million +33.9%5.6%6.1 $17.85 8/15/2023596,700 shares $11.04 million +21.8%4.2%6.3 $18.50 7/31/2023489,800 shares $11.43 million +13.6%3.4%5.8 $23.33 7/15/2023431,100 shares $10.75 million +13.9%3.0%5.5 $24.94 6/30/2023378,500 shares $9.83 million -17.7%2.6%4.7 $25.98 6/15/2023459,700 shares $12.32 million +0.1%3.2%6.2 $26.81 5/31/2023459,100 shares $12.44 million +2.3%N/A6.3 $27.09 5/15/2023449,000 shares $11.54 million +3.8%N/A5.4 $25.70 4/30/2023432,500 shares $11.10 million -6.1%3.0%5.3 $25.66 4/15/2023460,500 shares $12.77 million -0.5%3.2%5.7 $27.72 3/31/2023463,000 shares $13.30 million -0.7%3.2%5.8 $28.72 3/15/2023466,200 shares $12.55 million -11.8%3.3%5.3 $26.92 2/28/2023528,800 shares $16.76 million +3.2%3.7%5.7 $31.70 2/15/2023512,300 shares $15.82 million +1.6%3.6%5.8 $30.88 1/31/2023504,100 shares $15.63 million -7.1%3.5%5.3 $31.01 1/15/2023542,800 shares $16.83 million -17.3%3.8%5.4 $31.00Trump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absolute (Ad)Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. 12/30/2022656,200 shares $19.42 million +12.1%4.6%6.3 $29.60 12/15/2022585,600 shares $17.17 million -30.9%4.1%5.5 $29.32 11/30/2022847,400 shares $26.73 million -11.5%5.9%9 $31.54 11/15/2022957,100 shares $29.91 million -3.0%6.7%10.3 $31.25 10/31/2022987,100 shares $28.05 million -0.8%6.9%11.3 $28.42 10/15/2022994,800 shares $23.73 million +0.5%7.0%12.3 $23.85 9/30/2022989,600 shares $23.55 million +7.9%6.9%12.3 $23.80 9/15/2022917,300 shares $20.94 million -4.7%6.4%11 $22.83 8/31/2022962,000 shares $21.74 million -3.5%6.7%10.2 $22.60 8/15/2022996,600 shares $22.64 million -3.2%7.0%10.2 $22.72 7/31/20221,030,000 shares $24.06 million -1.9%7.6%9.5 $23.36 7/15/20221,050,000 shares $24.34 million No Change7.7%9.5 $23.18 6/30/20221,050,000 shares $23.44 million -7.9%7.7%9.5 $22.32 6/15/20221,140,000 shares $25.03 million +7.6%8.4%10.7 $21.96 5/31/20221,060,000 shares $23.04 million No Change7.4%11.1 $21.74 5/15/20221,060,000 shares $23.62 million -2.8%7.4%11.9 $22.28 4/30/20221,090,000 shares $23.47 million No Change7.7%12.5 $21.53 4/15/20221,090,000 shares $25.28 million -3.5%7.7%13.9 $23.19 3/31/20221,130,000 shares $28.37 million -4.2%7.9%13.4 $25.11 3/15/20221,180,000 shares $29.92 million +5.4%8.3%13 $25.36 2/28/20221,120,000 shares $36.40 million -1.8%7.9%12.1 $32.50 2/15/20221,140,000 shares $35.10 million +2.7%8.0%12.4 $30.79 1/31/20221,110,000 shares $35.30 million -0.9%7.8%11.7 $31.80 1/15/20221,120,000 shares $38.32 million +14.5%7.9%12.6 $34.21 12/31/2021978,200 shares $35.05 million +13.1%6.9%11.7 $35.83 12/15/2021864,600 shares $34.20 million +7.0%6.1%11.3 $39.56 11/30/2021807,800 shares $31.61 million +6.8%5.7%11.2 $39.13 11/15/2021756,300 shares $29.50 million -29.3%5.3%10.5 $39.01 10/29/20211,070,000 shares $44.57 million No Change7.5%15.5 $41.65 10/15/20211,070,000 shares $44.58 million +0.9%7.5%16 $41.66 9/30/20211,060,000 shares $45.11 million -12.4%7.4%15.4 $42.56 9/15/20211,210,000 shares $48.16 million +0.8%8.5%17 $39.80 8/31/20211,200,000 shares $51.76 million -4.8%8.4%15.3 $43.13 8/13/20211,260,000 shares $52.72 million -3.1%8.8%14.7 $41.84 7/30/20211,300,000 shares $52.17 million -0.8%9.1%14.7 $40.13 7/15/20211,310,000 shares $53.42 million -3.0%9.2%13.7 $40.78 6/30/20211,350,000 shares $58.44 million -8.8%9.5%13 $43.29 6/15/20211,480,000 shares $63.26 million -7.5%10.4%10.8 $42.74 5/28/20211,600,000 shares $74.64 million -1.2%11.2%12 $46.65 5/14/20211,620,000 shares $69.14 million -1.8%N/A11.5 $42.68 4/30/20211,650,000 shares $66.92 million -2.4%N/A11.1 $40.56 4/15/20211,690,000 shares $69.22 million +17.4%N/A11.3 $40.96 3/31/20211,440,000 shares $54.76 million +7.5%N/A9.7 $38.03 3/15/20211,340,000 shares $49.67 million +3.1%N/A10.8 $37.07 2/26/20211,300,000 shares $48.61 million -7.1%N/A10.6 $37.39 2/12/20211,400,000 shares $52.63 million -4.1%N/A12.3 $37.59 1/29/20211,460,000 shares $55.13 million -2.0%N/A13.7 $37.76 1/15/20211,490,000 shares $61.09 million -8.6%N/A14.1 $41.00 12/31/20201,630,000 shares $73.01 million -3.6%N/A15.9 $44.79 12/15/20201,690,000 shares $64.98 million -2.3%N/A16.3 $38.45Trump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absolute (Ad)Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. 11/30/20201,730,000 shares $66.21 million -2.8%N/A16.5 $38.27 11/15/20201,780,000 shares $67.30 million -1.7%N/A16.6 $37.81 10/30/20201,810,000 shares $60.71 million +3.4%N/A16.7 $33.54 10/15/20201,750,000 shares $65.71 million -3.3%N/A15.6 $37.55 9/30/20201,810,000 shares $64.06 million -11.7%N/A15.7 $35.39 9/15/20202,050,000 shares $73.29 million +1.0%N/A17.2 $35.75 8/31/20202,030,000 shares $77.81 million -0.5%N/A17.8 $38.33 8/14/20202,040,000 shares $72.97 million +1.0%N/A16.1 $35.77 7/31/20202,020,000 shares $73.53 million -2.4%N/A14.3 $36.40 7/15/20202,070,000 shares $75.20 million -1.9%N/A13.8 $36.33 6/30/20202,110,000 shares $79.61 million -1.4%N/A13.4 $37.73 6/15/20202,140,000 shares $72.72 million +4.4%N/A13.2 $33.98 5/29/20202,050,000 shares $68.74 million +9.6%N/A11 $33.53 5/15/20201,870,000 shares $54.62 million +4.5%N/A9.3 $29.21 4/30/20201,790,000 shares $59.48 million +0.6%N/A9 $33.23 4/15/20201,780,000 shares $52.62 million No ChangeN/A8.9 $29.56 3/31/20201,780,000 shares $59.45 million -5.2%N/A8.4 $33.40 3/13/20201,877,200 shares $61.63 million -21.1%N/A8.7 $32.83 2/28/20202,380,000 shares $60.43 million -13.8%N/A12.3 $25.39 2/14/20202,760,000 shares $104.22 million +0.7%N/A15.6 $37.76 1/31/20202,740,000 shares $115.77 million +15.6%N/A17.1 $42.25 1/15/20202,370,000 shares $99.16 million +3.0%N/A12.6 $41.84 12/31/20192,300,000 shares $100.95 million +7.0%N/A13.2 $43.89 10/15/20192,020,000 shares $121.64 million -10.2%15.1%9.8 $60.22 ANIK Short Interest - Frequently Asked Questions What is Anika Therapeutics' current short interest? Short interest is the volume of Anika Therapeutics shares that have been sold short but have not yet been closed out or covered. As of August 31st, investors have sold 676,700 shares of ANIK short. 4.74% of Anika Therapeutics' shares are currently sold short. Learn More on Anika Therapeutics' current short interest. What is a good short interest ratio for Anika Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ANIK shares currently have a short interest ratio of 14.0. Learn More on Anika Therapeutics's short interest ratio. Which institutional investors are shorting Anika Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Anika Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Anika Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.74% of Anika Therapeutics' floating shares are currently sold short. Is Anika Therapeutics' short interest increasing or decreasing? Anika Therapeutics saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 676,700 shares, an increase of 0.2% from the previous total of 675,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Anika Therapeutics' float size? Anika Therapeutics currently has issued a total of 14,800,000 shares. Some of Anika Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Anika Therapeutics currently has a public float of 14,290,000 shares. How does Anika Therapeutics' short interest compare to its competitors? 4.74% of Anika Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Anika Therapeutics: Atrion Co. (3.25%), Cerus Co. (3.46%), OraSure Technologies, Inc. (2.76%), Utah Medical Products, Inc. (1.54%), West Pharmaceutical Services, Inc. (2.12%), The Cooper Companies, Inc. (1.01%), Align Technology, Inc. (3.93%), Merit Medical Systems, Inc. (4.78%), DENTSPLY SIRONA Inc. (8.69%), ICU Medical, Inc. (4.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.11 billion), Canadian Natural Resources Limited ($4.04 billion), Suncor Energy Inc. ($3.19 billion), Aptiv PLC ($2.56 billion), Paychex, Inc. ($2.48 billion), Cencora, Inc. ($2.28 billion), Onsemi ($2.08 billion), Moderna, Inc. ($1.98 billion), Tractor Supply ($1.93 billion), and International Paper ($1.93 billion). View all of the most shorted stocks. What does it mean to sell short Anika Therapeutics stock? Short selling ANIK is an investing strategy that aims to generate trading profit from Anika Therapeutics as its price is falling. ANIK shares are trading up $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Anika Therapeutics? A short squeeze for Anika Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ANIK, which in turn drives the price of the stock up even further. How often is Anika Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANIK, twice per month. The most recent reporting period available is August, 31 2024. More Short Interest Resources from MarketBeat Related Companies: ATRI Short Interest Data CERS Short Interest Data OSUR Short Interest Data UTMD Short Interest Data WST Short Interest Data COO Short Interest Data ALGN Short Interest Data MMSI Short Interest Data XRAY Short Interest Data ICUI Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ANIK) was last updated on 9/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | SponsoredMore Than 30 Federal Agencies Buy From This Cybersecurity TechIn January of 2022 Ukraine was hit by an especially nasty piece of malware, named WhisperGate. By then Ukra...Capital Trends | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anika Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anika Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANIK Stock Alerts